BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

53 related articles for article (PubMed ID: 11012227)

  • 1. Platelet immunoregulatory factors.
    Tykocinski ML; Xiong N; Morrow DM
    Stem Cells; 1996; 14 Suppl 1():240-5. PubMed ID: 11012227
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Hematopoietic placental protein 14. An immunosuppressive factor in cells of the megakaryocytic lineage.
    Morrow DM; Xiong N; Getty RR; Ratajczak MZ; Morgan D; Seppala M; Riittinen L; Gewirtz AM; Tykocinski ML
    Am J Pathol; 1994 Dec; 145(6):1485-95. PubMed ID: 7992851
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Pregnancy zone protein is a carrier and modulator of placental protein-14 in T-cell growth and cytokine production.
    Skornicka EL; Kiyatkina N; Weber MC; Tykocinski ML; Koo PH
    Cell Immunol; 2004; 232(1-2):144-56. PubMed ID: 15882859
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The effect of human placental protein 14 (PP14) on the production of interleukin-1 from mitogenically stimulated mononuclear cell cultures.
    Pockley AG; Bolton AE
    Immunology; 1990 Feb; 69(2):277-81. PubMed ID: 2307483
    [TBL] [Abstract][Full Text] [Related]  

  • 5. alpha2-macroglobulin modulates the immunoregulatory function of the lipocalin placental protein 14.
    Riely GJ; Rachmilewitz J; Koo PH; Tykocinski ML
    Biochem J; 2000 Oct; 351 Pt 2(Pt 2):503-8. PubMed ID: 11023837
    [TBL] [Abstract][Full Text] [Related]  

  • 6. alpha2,6-Sialylation promotes binding of placental protein 14 via its Ca2+-dependent lectin activity: insights into differential effects on CD45RO and CD45RA T cells.
    Ish-Shalom E; Gargir A; André S; Borovsky Z; Ochanuna Z; Gabius HJ; Tykocinski ML; Rachmilewitz J
    Glycobiology; 2006 Mar; 16(3):173-83. PubMed ID: 16269626
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Negative regulation of T cell activation by placental protein 14 is mediated by the tyrosine phosphatase receptor CD45.
    Rachmilewitz J; Borovsky Z; Riely GJ; Miller R; Tykocinski ML
    J Biol Chem; 2003 Apr; 278(16):14059-65. PubMed ID: 12556471
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Placental protein 14 functions as a direct T-cell inhibitor.
    Rachmilewitz J; Riely GJ; Tykocinski ML
    Cell Immunol; 1999 Jan; 191(1):26-33. PubMed ID: 9918684
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Placental protein 14 (PP14) inhibits the synthesis of interleukin-2 and the release of soluble interleukin-2 receptors from phytohaemagglutinin-stimulated lymphocytes.
    Pockley AG; Bolton AE
    Clin Exp Immunol; 1989 Aug; 77(2):252-6. PubMed ID: 2789118
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Platelet factor 4 mRNA expression in human erythroleukemic cells: regulation by phorbol esters and certain cytokines.
    Hunt P; Hokom MM; Fisher CA; Jacobsen FW; Wiemann B; Martin FH
    Exp Hematol; 1991 Sep; 19(8):779-84. PubMed ID: 1868892
    [TBL] [Abstract][Full Text] [Related]  

  • 11. A receptor for the lipocalin placental protein 14 on human monocytes.
    Miller RE; Fayen JD; Chakraborty S; Weber MC; Tykocinski ML
    FEBS Lett; 1998 Oct; 436(3):455-60. PubMed ID: 9801168
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Platelet-derived transforming growth factor-beta down-regulates NKG2D thereby inhibiting natural killer cell antitumor reactivity.
    Kopp HG; Placke T; Salih HR
    Cancer Res; 2009 Oct; 69(19):7775-83. PubMed ID: 19738039
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Suppression of in vitro lymphocyte reactivity to phytohemagglutinin by placental protein 14.
    Pockley AG; Mowles EA; Stoker RJ; Westwood OM; Chapman MG; Bolton AE
    J Reprod Immunol; 1988 Jun; 13(1):31-9. PubMed ID: 3418616
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Structural studies, localization in tissue and clinical aspects of human endometrial proteins.
    Seppälä M; Riittinen L; Julkunen M; Koistinen R; Wahlström T; Iino K; Alfthan H; Stenman UH; Huhtala ML
    J Reprod Fertil Suppl; 1988; 36():127-41. PubMed ID: 3057195
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Placental protein 14 (PP14) content and immunosuppressive activity of human cervical mucus.
    Pockley AG; Barratt CL; Bolton AE
    Symp Soc Exp Biol; 1989; 43():317-23. PubMed ID: 2641412
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Identification of placental protein 14 as an immunosuppressive factor in human reproduction.
    Bolton AE; Pockley AG; Clough KJ; Mowles EA; Stoker RJ; Westwood OM; Chapman MG
    Lancet; 1987 Mar; 1(8533):593-5. PubMed ID: 2881133
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Glycodelin A, not glycodelin S, is apoptotically active. Relevance of sialic acid modification.
    Mukhopadhyay D; SundarRaj S; Alok A; Karande AA
    J Biol Chem; 2004 Mar; 279(10):8577-84. PubMed ID: 14679205
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Cytokine mRNA expression in human platelets and a megakaryocytic cell line and cytokine modulation of platelet function.
    Soslau G; Morgan DA; Jaffe JS; Brodsky I; Wang Y
    Cytokine; 1997 Jun; 9(6):405-11. PubMed ID: 9199874
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Gender-specific glycosylation of human glycodelin affects its contraceptive activity.
    Morris HR; Dell A; Easton RL; Panico M; Koistinen H; Koistinen R; Oehninger S; Patankar MS; Seppala M; Clark GF
    J Biol Chem; 1996 Dec; 271(50):32159-67. PubMed ID: 8943270
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Progesterone and human chorionic gonadotropin do not stimulate placental proteins 12 and 14 or prolactin production by human decidual tissue in vitro.
    Ren SG; Braunstein GD
    J Clin Endocrinol Metab; 1990 Apr; 70(4):983-9. PubMed ID: 2318953
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 3.